General MedicineSchedule H Prescription Drug
Metrotus-400
Metronidazole 400mg
Statutory Prescription Notice (Schedule H / H1 Drug)
Avoid alcohol consumption during therapy and for at least 48 hours after treatment completion.
Product Overview
Antiprotozoal and anaerobic antimicrobial formulation.
Technical & Regulatory Specifications
| Brand Name | Metrotus-400 |
|---|---|
| Generic / INN Name | Metronidazole Tablets IP |
| Active Composition | Metronidazole 400mg |
| Dosage Strength | 400mg |
| Dosage Form | Film-coated Tablets |
| Packaging Presentation | Blister Strip |
| Therapeutic Category | General Medicine |
| Drug Classification | Schedule H Prescription Drug |
| Marketed By | Habbatus Pharmaceuticals Pvt. Ltd. |
| Manufacturing Standard | Qualified Partner Facility (GMP Certified Facility) |
Professional Reference Notice
This product summary is prepared exclusively for the informational reference of registered medical practitioners, dental surgeons, and licensed pharmacists in India. Not for consumer self-medication.